echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Huabang pharmaceutical chemical linamine tablets approved by the State Drug Administration

    Huabang pharmaceutical chemical linamine tablets approved by the State Drug Administration

    • Last Update: 2020-06-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, HuabangHealth(http://issued a notice that its wholly-owned sub-
    company(http://Chongqing HuabangPharmaceutical(http://Co., Ltd("Huabang Pharmaceuticals") has been approved by the StateMedicines(http://Regulatory Authority to issue the "drug registration approval" of the chemical drug linazole tabletsAbout linazineaminelinazole is a gysaketone antibiotic that is primarily used to treat infections caused by gram-positive (G-) cocci, including suspected or confirmed hospital acquired pneumonia (HAM), community-acquired pneumonia (CAP), complex skin or skin soft tissue infection (SSTI), and v.aAccording to the announcement, Linaiamine tablets are "National BasicMedical(http://Insurance, Work Injury Insurance and Maternity Insurance Catalog" Class B drugs, Huabang Pharmaceuticals is the first domestic company to obtain the production approval company, and has been included in the "China List of Drugs Listed."According to data from the ChinaPharmaceutical(http://Industrial Information Center
    The Integrated Database of Drug(http://(PDB) in key urban sample hospitals, the total domestic sales of linazine tablets in 2018 was about 110 million yuan
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.